K
Kerin L. Tyrrell
Researcher at Michigan State University
Publications - 61
Citations - 2584
Kerin L. Tyrrell is an academic researcher from Michigan State University. The author has contributed to research in topics: Bacteroides fragilis & Anaerobic bacteria. The author has an hindex of 27, co-authored 60 publications receiving 2265 citations.
Papers
More filters
Journal ArticleDOI
Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938.
TL;DR: Based on phenotypic, chemotaxonomic and phylogenetic analyses, novel genus Clostridioides gen. nov. is proposed for Clastridium difficile as Clostidioides difficILE gen. comb.
Journal ArticleDOI
Lactobacillus Species: Taxonomic Complexity and Controversial Susceptibilities
TL;DR: Lactobacillus species are generally acid resistant and are able to survive ingestion and are generally resistant to metronidazole, aminoglycosides and ciprofloxacin with L. acidophilus and L. casei being susceptible to penicillin and vancomycin.
Journal ArticleDOI
16S-23S rDNA internal transcribed spacer sequences for analysis of the phylogenetic relationships among species of the genus Fusobacterium.
G. Conrads,M. C. Claros,Diane M. Citron,Kerin L. Tyrrell,Vreni Merriam,Ellie J. C. Goldstein +5 more
TL;DR: The results confirmed the strikingly distant relationship between Fusobacterium prausnitzii and the genus FusOBacterium and found the ITS region to consist both of conserved motifs, which functioned as a framework for alignment, and of variable sites, which provided high phylogenetic resolution.
Journal ArticleDOI
In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp.
Ellie J. C. Goldstein,Diane M. Citron,C. Vreni Merriam,Yumi A. Warren,Kerin L. Tyrrell,Helen T. Fernandez +5 more
TL;DR: The activity of TD-6424 was similar to that of quinupristin-dalfopristin for most strains except C. ramosum, Eubacterium lentum, and Lactobacillus plantarum strains, which has potential for use against infections with gram-positive anaerobes and deserves further clinical evaluation.
Journal ArticleDOI
In Vitro Activities of Dalbavancin and Nine Comparator Agents against Anaerobic Gram-Positive Species and Corynebacteria
Ellie J. C. Goldstein,Diane M. Citron,C. Vreni Merriam,Yumi A. Warren,Kerin L. Tyrrell,Helen T. Fernandez +5 more
TL;DR: Dalbavancin exhibited excellent activity against gram-positive strains tested and warrants clinical evaluation, 1 to 3 dilutions more active than vancomycin against most strains.